Regular price
124.320
/
-
Erenumab
- In Stock
- Inventory on the way
Migraine Blocker
Fast Relief
Targeted Action
Long-Lasting
Easy Use
Aimovig is a prescription medicine used to help prevent migraine in adults.
Aimovig is the first FDA-approved treatment that blocks the CGRP receptor to help prevent migraine.
Aimovig is the first FDA-approved treatment that blocks the CGRP receptor to help prevent migraine.
Recommended dosage is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly.
Administer in the abdomen, thigh, or upper arm subcutaneously.
- Pain relief
- Antipyretic